Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | CAICaris Life Sciences, Inc.FY2025 · Dec |
|---|---|
| Revenue | $812.03M |
| Revenue, yoy | +97.0% |
| Net income | $68.09M |
| Net income, yoy | +75.8% |
| Net margin | -8.4% |
| Free cash flow | $66.90M |
| FCF margin | 8.2% |
| EPS, diluted | $3.22 |
Add another company.